DUKE Robotics Corp.
For the period ended Dec 31, 2025. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
On May 27, 2021, our board of directors approved the 2021 Plan pursuant to which the Company may issue awards, from time to time, consisting of non-qualified stock options, restricted stock grants and restricted stock units. In addition, stock option awards that qualify under Section 102 of the Israeli Tax Ordinance (New Version) 1961 (the “ITO”), and/or under Section 3(i) of the ITO, may be granted. On March 10, 2026, the board of directors approved the following grants: (i) options to purchase 16,000 shares of our common stock to each of Yossef Balucka, our Chief Executive Officer, and Erez Nachtomy, our Vice Chairman; (ii) options to purchase 10,000 shares of our common stock to Shlomi Zakai, our Chief Financial Officer; and (iii) options to purchase 4,000 shares of our common stock to each of Vadim Maor, our Chief Technology Officer, Eran Antebi, a member of our board of directors, and Keren Gousman, a member of our board of directors. Each of the aformentioned options have an exercise price of $7.88 per share, a term of six (6) years from issuance and vest over a three (3) year period, with one third vesting on each of the first three anniversaries of the dates of grant.
On March 9, 2026, Mr. Sagiv Aharon resigned from the Board of Directors, effective as of such date. Mr. Aharon’s resignation did not result from any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Effective March 10, 2026, Mr. Aharon will sit on our Advisory Board and we have entered into a consulting agreement with him and have agreed to pay him a fee of $5,000 per month.
On March 10, 2026, our board of directors approved the appointments of Mr. Yehoshua Abramovich and Mr. Ran Ben Yehuda to our Advisory Board, and we have entered into consulting agreements with each of them, effective February 1, 2026, and have agreed to grant them options to purchase 16,000 shares of our common stock and pay each of them a fee of $4,000 per month.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.